Jean-François Labbé
Presidente presso NICOX SA
Relazioni attive
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Michele Garufi | M | 70 |
Nicox Ophthalmics, Inc.
 Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 28 anni |
| Les Kaplan | M | 73 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 10 anni |
| Lauren Silvernail | F | 65 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 7 anni |
| Gavin M. Spencer | M | 53 | 19 anni | |
| Lucie Larguier | F | - | 8 anni | |
| Luzi Andreas von Bidder | M | 71 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 10 anni |
| Adrienne Graves | M | 69 |
Nicox Ophthalmics, Inc.
Nicox Ophthalmics, Inc. Pharmaceuticals: MajorHealth Technology Nicox Ophthalmics, Inc. develops ocular diseases treatment products. It offers extensive pipeline such as a number of clinical and pre-clinical programs that principally target ocular allergy, ocular inflammation, and blepharitis. The company was founded by Thomas Cavanagh on December 21, 2007 and is headquartered in Fort Worth, TX. | 10 anni |
| Jean-Luc Bélingard | M | 74 | 21 anni | |
| Marie-Yvonne Landel-Meunier | F | 71 | 7 anni | |
| Maya Said | M | 47 | 7 anni | |
| John Felitti | M | 54 | 8 anni | |
| Betty Quentin | F | - |
Centravet
 Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Guillaume Raunet | M | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Marie Bodier | F | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Olivier Fortineau | M | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Murielle Vabret | M | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Aurélie Rouquet | F | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Isabelle Grignon | F | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Loïc Guiouillier | M | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Michaël Delbouvry | M | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Frédéric Stahl | M | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Frédéric Cuadrado | M | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Caroline Rousseau | F | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Nathalie Lejeau | F | - |
Centravet
Centravet Agricultural Commodities/MillingProcess Industries Centravet operates as a veterinary distribution center, which supplies medicine, food and material practitioners and to promote the veterinary surgeon. It offers TransNet, ivet, GmVet, Pilehairs, and Webveto solutions. The company was founded in 1972 and is headquartered in Taden, France. | - |
| Emmanuelle Pierry | F | - | 22 anni | |
| Maud Brandely | M | 70 | 8 anni | |
| Sandrine Gestin | F | 56 | 25 anni | |
| Eric Quéméneur | M | 60 | 10 anni | |
| Doug Hubatsch | M | - | 3 anni |
Grafico relazionale
Relazione in diverse aziende
Relazioni precedenti
| Nome | Sesso | Età | Società collegate | Collaborazione |
|---|---|---|---|---|
| Antoine Béret | M | 79 | - | |
| Wim van Bree | M | - |
SpePharm Holding BV
 SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | 7 anni |
| Birgit Stattin Norinder | F | 75 | 7 anni | |
| Vaughn M. Kailian | M | 79 | 13 anni | |
| Laurence Zitvogel | M | 60 | - | |
| Philippe Masquida | M | 62 | 4 anni | |
| Nathalie Adda | M | 58 | 3 anni | |
| Bengt Ingemar Samuelsson | M | 90 | 15 anni | |
| Manju Patel | M | - |
Pfizer Group Ltd.
 Pfizer Group Ltd. Pharmaceuticals: MajorHealth Technology Part of Pfizer Inc., Pfizer Group Ltd. is a British company that manufactures and sells pharmaceuticals, animal health products, and healthcare products. The private company is based in Sandwich, UK. | - |
| Hans Vos | M | - |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | - |
| Antoine Aulanier | M | - |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | 5 anni |
| Ad Velders | M | - |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | 5 anni |
| Sanjiv Sharma | M | 68 | 3 anni | |
| Gerardus A. Hoogland | M | 68 |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | - |
| Patrick Mahieux | M | 60 | - | |
| Colin Freund | M | 54 | 2 anni | |
| Catherine Mathis | M | 58 | 20 anni | |
| Neil L. Brown | M | - |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | - |
| Jérôme d’Enfert | M | - |
Hoechst Marion Roussel SA
| - |
| Elisabeth Keppi | F | 64 | 26 anni | |
| Francois Ducret | M | - | - | |
| Christine Guillen | M | - | 6 anni | |
| Stephane Nicolas | M | 55 | - | |
| Dominique Even | M | - |
Hoechst Marion Roussel SA
| - |
| Michael Bergamini | M | - | 5 anni | |
| Tomas Navratil | M | 47 | - | |
| Géraldine Honnet | M | - | 4 anni | |
| Caroline Dumas | M | - |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | - |
| Jørgen Buus Lassen | M | 90 | 24 anni | |
| Evelyne Nguyen | F | 56 | - | |
| Ross MaClean | M | - |
DrugAbuse Sciences SAS
 DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | - |
| John Kelley | M | 70 |
Hoechst Marion Roussel SA
| 4 anni |
| Peter W. Ladell | M | 80 |
Hoechst Marion Roussel SA
| 2 anni |
| Frank Baldino | M | 71 | 9 anni | |
| Vicente J. Anido | M | 71 | 1 anni | |
| James Gale | M | 74 |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | - |
| Lionel Leventhal | M | - |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | - |
| Michel Dubois | M | 81 | 4 anni | |
| Marc Dunoyer | M | 71 |
Hoechst Marion Roussel SA
| - |
| Göran Albert Ando | M | 75 | 7 anni | |
| Mathieu Bigois | M | - |
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | - |
| Andreas Segerros | M | 63 | 2 anni | |
| Michel Gréco | M | 80 |
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | - |
| Gilles Avenard | M | - |
Hoechst Marion Roussel SA
| 7 anni |
| Harrold van Barlingen | M | 58 |
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | - |
| Thierry Laugel | M | 57 |
DrugAbuse Sciences SAS
DrugAbuse Sciences SAS Pharmaceuticals: MajorHealth Technology DrugAbuse Sciences SAS develops therapies for treatment of alcohol abuse and opiate addiction. It also operates an educational website which is designed to provide clinicians, patients access to information and services related to alcohol abuse treatment and care. The company is headquartered in Lyon, France | - |
| Hubert Birner | M | 57 |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | 4 anni |
| Hemanshu Shah | M | 63 | - | |
| Flemming Ørnskov | M | 66 |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | - |
| Stéphane Boissel | M | 56 | 4 anni | |
| Gerald W. St. Peter | M | 57 | - | |
| Karl-Gerhard Seifert | M | - |
SpePharm Holding BV
SpePharm Holding BV Pharmaceuticals: MajorHealth Technology SpePharm is a European specialty pharmaceutical company focused on acquiring, registering and marketing high medical value specialty medicines, essentially for the hospital market. Particular therapeutic areas of interest are in oncology and hematology, critical and supportive care. SpePharm aims to be the preferred partner for pharmaceutical and biotechnology companies, especially those from outside of Europe, seeking to maximize product and commercial opportunities within Europe. The vision of SpePharm is to become a leading specialty pharmacy company offering the first truly pan-European commercial platform for high value niche hospital and specialist products. The company was founded in September 2006 by Jean-François Labbé together with leading life-science investment firms, TVM Capital (Germany) and Signet Healthcare Partners, part of the Sanders Morris Harris Group Inc (USA). SpePharm headquarters are located in Amsterdam, The Netherlands. Its European operations are run from its French subsidiary, SpePharm SAS, in Paris, France. Since January 2008, Spepharm is also present in Europe through subsidiaries in Italy (Milan), Germany (Munich), The United-Kingdom (Oxford) and Denmark (Copenhagen) for the Nordic countries. | - |
| Pascal Pfister | M | 66 | 5 anni | |
| Eric Castaldi | M | 59 | 16 anni | |
| José Boyer | M | - | - |
Statistiche
| Paese | Relazioni | % del totale |
|---|---|---|
| Francia | 71 | 84.52% |
| Paesi Bassi | 12 | 14.29% |
| Stati Uniti | 5 | 5.95% |
| Regno Unito | 1 | 1.19% |
Età delle relazioni
Attive
Scorse
Uomo
Donna
Amministratori
Dirigenti
Provenienza delle relazioni
- Borsa valori
- Insiders
- Jean-François Labbé
- Contatti personali
